Windlas Biotech Completes Buyback and Extinguishment of 4.7 Lakh Equity Shares
Windlas Biotech Limited successfully completed the buyback and subsequent extinguishment of 4,70,000 fully paid-up equity shares of its capital. The company confirmed the transaction, which took place on May 18, 2026.The buyback process was initiated following a Public Announcement dated April 18, 2026, which was published on April 20, 2026. The tendering period for the buyback opened on April 30, 2026, and concluded on May 07, 2026. During this period, the company acquired 4,70,000 fully paid-up equity shares, each having a face value of INR 5. These shares were bought back from eligible shareholders on a proportionate basis at a price of INR 1,000 per share, payable in cash.
Share Capital Reconciliation
The extinguishment of the 4,70,000 shares significantly impacted the company's share capital structure. A reconciliation of the share capital details was reported as follows:| Particulars | Number of Equity Shares | Equity Share Capital (In INR) |
|---|---|---|
| Paid-up equity share capital (Pre- Buyback) | 2,11,06,229 | 10,55,31,145 |
| Less: Total Equity Shares extinguished (Buyback) | 4,70,000 | 23,50,000 |
| Paid-up equity share capital (Post Buyback) | 2,06,36,229 | 10,31,81,145 |
Impact on Shareholding Pattern
The buyback also altered the shareholding pattern of Windlas Biotech Limited. The shift in ownership was observed between the pre-buyback and post-buyback periods:| Shareholder Category | Pre-Buyback Shares | % of Pre-Buyback Capital | Post-Buyback Shares | % of Post-Buyback Capital |
|---|---|---|---|---|
| Promoters and persons acting in concert | 1,30,65,352 | 61.90 | 1,30,65,352 | 63.31 |
| Foreign Investors | 4,66,484 | 2.21 | 75,70,877 | 36.69 |
| Indian Financial Institutions/ Banks/Mutual Funds/Govt. Companies | 24,52,250 | 11.62 | 75,70,877 | 36.69 |
| Public including other Bodies Corporate | 51,22,143 | 24.27 | 75,70,877 | 36.69 |
| Total | 2,11,06,229 | 100.00 | 2,06,36,229 | 100.00 |
WINDLAS Stock Price Movement
Shares of Windlas Biotech Limited today slipped by 0.19% to settle at ₹776.2. Trading saw 36,067 shares transacted during the session, adding modest pressure to the stock's price movements.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.